InflammaZoom Careers Forum

Watch the on-demand recording - available now


Meeting overview


The InflammaZoom Careers Forum brings together researchers worldwide to share new findings and foster collaborations within the innate immune research community. Researchers have the opportunity to present their work to gain valuable feedback from their peers and elevate their presence within the community.

This virtual conference is an extension of the monthly webinar series on innate immunity and inflammasome biology, InflammaZoom, established by by Professor Clare Bryant (Cambridge Immunology Network chair) in 2020. 

Scientific organizers

  • Dave Boucher (University of York, UK)
  • Clare Bryant (University of Cambridge, UK)
  • David Brough (University of Manchester, UK)
  • Paras Anand (Imperial College London, UK)
  • Avinash Shenoy (Imperial College London, UK)
  • Rebecca Coll (Queen's University Belfast, UK)
  • Clare Bryant (University of Cambridge, UK)
    David Brough (University of Manchester, UK)
    Paras Anand (Imperial College London, UK)
    Avinash Shenoy (Imperial College London, UK)
    Dave Boucher (University of York, UK)
    Rebecca Coll (Queen's University Belfast, 



Keynote speaker
​

  • Professor Andreas Strasser - Walter and Eliza Hall Institute of Medical Research (WEHI), Australia
    • "Learning the mechanisms of programmed cell death to develop novel therapies for cancer"

Selected short talks

  • Cassandra R Harapas - Walter and Eliza Hall Institute of Medical Research, Australia
    • “DPP9 deficiency: an Inflammasomopathy which can be rescued by lowering NLRP1/IL-1 signaling”
  • Lotte Spel - University of Lausanne, Switzerland
    • “HSP90β function separates wild type from disease-associated NLRP3 inflammasome activity”
  • Damien Bertheloot - Institute of Innate Immunity, University of Bonn, Germany
    • “Inhibitory nanobodies against ASC disassemble post-pyroptotic inflammasomes and ameliorate inflammatory diseases”
  •  Fabian Fischer - The Kennedy Institute of Rheumatology, University of Oxford, UK
    • “TBK1 and IKKɛ act like an OFF switch to limit NLRP3 inflammasome pathway activation”
  •  Liudmila Andreeva - Harvard Medical School, USA
    • “Full-length NLRP3 Forms Oligomeric Cages to Mediate NLRP3 Activation”
  •  Swarna Beesetti - St Jude Children’s Research Hospital, USA
    • “MCC950: Magical drug for Fanconi anemia patients” (Not available on-demand)